Virginie Maire

1.1k total citations
17 papers, 697 citations indexed

About

Virginie Maire is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Virginie Maire has authored 17 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Virginie Maire's work include Cancer-related Molecular Pathways (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Cancer-related gene regulation (3 papers). Virginie Maire is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Cancer-related gene regulation (3 papers). Virginie Maire collaborates with scholars based in France, United States and Singapore. Virginie Maire's co-authors include Thierry Dubois, Guillem Rigaill, Gordon C. Tucker, Francisco Cruzalegui, Florence Dumas, G Benoît, Sylvain Loric, Pascal Eschwège, P. Blanchet and Bernard Lacour and has published in prestigious journals such as The Lancet, PLoS ONE and Cancer Research.

In The Last Decade

Virginie Maire

16 papers receiving 685 citations

Peers

Countries citing papers authored by Virginie Maire

Since Specialization

Citations

This map shows the geographic impact of Virginie Maire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Maire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Maire more than expected).

Fields of papers citing papers by Virginie Maire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Maire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Maire. The network helps show where Virginie Maire may publish in the future.

Co-authorship network of co-authors of Virginie Maire

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Maire. A scholar is included among the top collaborators of Virginie Maire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Maire. Virginie Maire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	The mechanism of nesprin-2 accumulation at the nucleus front during confined cell migration 2025 ·Biophysical Journal ·(unknown), (unknown), Virginie Maire, Thierry Dubois, Alain Karma, Vincent Hakim, Cécile Sykes	0
2	HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers 2023 ·Molecular Oncology ·Rania El Botty, Sophie Vacher, (unknown), Adrien Briaux, (unknown), Ahmed Dahmani, Élodie Montaudon, Fariba Némati, Léa Huguet, Laura Sourd, (unknown), Sophie Château‐Joubert, Thierry Dubois, Virginie Maire, Rosette Lidereau, Audrey Rapinat, David Gentien, Florence Coussy, Ivan Bièche, Elisabetta Marangoni	5
3	Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses 2020 ·Molecules ·(unknown), Virginie Maire, Thierry Dubois, Abdelmajid Zyad	38
4	Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers 2019 ·Cancer Medicine ·(unknown), (unknown), Virginie Maire, (unknown), Fariba Némati, Laëtitia Lesage, Fabienne Pierre, Mengliang Ye, (unknown), (unknown), Didier Meseure, Nicolás André, Guillem Rigaill, Elisabetta Marangoni, Elaine Del Nery, Sergio Roman‐Roman, Thierry Dubois	57
5	Le monde fascinant des stars du digital 2019 ·Virginie Maire	3
6	LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers 2018 ·Oncotarget ·Sylvie Maubant, Tania Tahtouh, (unknown), Virginie Maire, Fariba Némati, Bruno Tesson, Mengliang Ye, Guillem Rigaill, (unknown), Aurélie Dumont, David Gentien, Bérengère Marty-Prouvost, Leanne de Koning, (unknown), Didier Decaudin, Francisco Cruzalegui, Gordon C. Tucker, Sergio Roman‐Roman, Thierry Dubois	20
7	LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors 2018 ·Cancer Medicine ·Virginie Maire, Faisal Mahmood, Guillem Rigaill, Mengliang Ye, (unknown), Fariba Némati, David Gentien, Gordon C. Tucker, Sergio Roman‐Roman, Thierry Dubois	18
8	Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells 2015 ·PLoS ONE ·Sylvie Maubant, Bruno Tesson, Virginie Maire, Mengliang Ye, Guillem Rigaill, David Gentien, Francisco Cruzalegui, Gordon C. Tucker, Sergio Roman‐Roman, Thierry Dubois	61
9	Abstract 41: The Wnt3a targetome in triple-negative breast cancer cell lines 2015 ·Cancer Research ·Sylvie Maubant, Bruno Tesson, Virginie Maire, Mengliang Ye, Guillem Rigaill, David Gentien, Francisco Cruzalegui, Gordon C. Tucker, Sergio Roman‐Roman, Thierry Dubois	2
10	Abstract 2764: The depletion of LRP5, unlike that of LRP6, promotes apoptosis in triple-negative breast cancer cells, making it an interesting therapeutic target 2014 ·Cancer Research ·Sylvie Maubant, Virginie Maire, Bruno Tesson, Fariba Némati, David Gentien, Bérengère Marty-Prouvost, Stéphane Depil, Francisco Cruzalegui, Gordon C. Tucker, Sergio Roman‐Roman, Thierry Dubois	1
11	TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer 2013 ·PLoS ONE ·Virginie Maire, Céline Baldeyron, Marion Richardson, Bruno Tesson, Anne Vincent‐Salomon, Eléonore Gravier, Bérengère Marty-Prouvost, Leanne de Koning, Guillem Rigaill, Aurélie Dumont, David Gentien, Emmanuel Barillot, Sergio Roman‐Roman, Stéphane Depil, Francisco Cruzalegui, Alain Pierré, Gordon C. Tucker, Thierry Dubois	119
12	Transducing properties of a pre-structured α-helical DPT-peptide containing a short canine adenovirus type 2 E4orf4 PP2A1-binding sequence 2013 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·(unknown), (unknown), Virginie Maire, Pierre B. Falanga, Xavier Cayla, Byron Baron, Patrick England, Alphonse Garcı́a	5
13	Abstract 4373: LRP5: a potential therapeutic target in triple-negative breast cancer. 2013 ·Cancer Research ·Sylvie Maubant, Virginie Maire, Bruno Tesson, David Gentien, Bérengère Marty-Prouvost, Francisco Cruzalegui, Stéphane Depil, Gordon C. Tucker, Sergio Roman‐Roman, Thierry Dubois	1
14	The Combinatorial PP1-Binding Consensus Motif (R/K)x (0,1)V/IxFxx(R/K)x(R/K) Is a New Apoptotic Signature 2010 ·PLoS ONE ·(unknown), Julien Guergnon, Virginie Maire, (unknown), Alphonse Garcı́a	10
15	Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells 2008 ·Breast Cancer Research ·(unknown), Virginie Maire, Eléonore Gravier, Guillem Rigaill, Anne Vincent‐Salomon, (unknown), Ingrid Lebigot, (unknown), (unknown), Pierre Gestraud, Philippe Hupé, Emmanuel Barillot, Francisco Cruzalegui, Gordon C. Tucker, Marc‐Henri Stern, Jean Paul Thiery, John A. Hickman, Thierry Dubois	170
16	[Evaluation and interest in new molecular markers in colon cancer]. 1998 ·PubMed ·Virginie Maire, (unknown), (unknown), Florence Dumas, B. Landi, (unknown), Paul‐Henri Cugnenc, F Gayral, Bernard Lacour, Sylvain Loric	6
17	Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy 1995 ·The Lancet ·Pascal Eschwège, P. Blanchet, G Benoît, A Jardin, Florence Dumas, Virginie Maire, Bernard Lacour, Sylvain Loric	181

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact